[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"options:asyncdata:cojl4zJSBdKzKQpGXZqrRSQmA-UNjcGhZlfOKCONY5g":3},{"blogPost":4,"otherBlogs":83},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":29,"class_list":30,"featured_media_src_url":38,"_links":39},778,"2026-11-11T17:57:22",{"rendered":8},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=778","nci-k-leads-national-efforts-to-integrate-comprehensive-cancer-education-into-health-professional-training-in-kenya","publish","post","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F11\u002F11\u002Fnci-k-leads-national-efforts-to-integrate-comprehensive-cancer-education-into-health-professional-training-in-kenya\u002F",{"rendered":14},"NCI-K Leads National Efforts to Integrate Comprehensive Cancer Education into Health Professional Training in Kenya.",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) has convened a two-day National Consultative Workshop aimed at strengthening cancer education in pre-service health professional training programmes across the country.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Held from 10–11 November 2026, the workshop brought together stakeholders to deliberate on ways of integrating comprehensive cancer education into the curricula of health professional training institutions, ensuring that future healthcare workers are adequately equipped with the knowledge and competencies needed to address the growing cancer burden in Kenya.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"565\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps-1024x565.jpg\" alt=\"\" class=\"wp-image-779\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps-1024x565.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps-300x166.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps-767x423.jpg 767w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps.jpg 1508w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Participants and stakeholders during the two-day national workshop on integrating comprehensive cancer education into health professional training programmes in Kenya.\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Lucy Musyoka, Director of Standards and Regulation at the Ministry of Health, represented Ms. Mary Muthoni Muriuki, Principal Secretary, State Department for Public Health and Professional Standards, at the workshop.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1462\" height=\"1012\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F4-talking.jpg\" alt=\"\" class=\"wp-image-780\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F4-talking.jpg 1462w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F4-talking-300x208-1.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F4-talking-767x531.jpg 767w\" sizes=\"auto, (max-width: 1462px) 100vw, 1462px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Dr. Lucy Musyoka, Director of Standards and Regulation at the Ministry of Health, addressing participants.\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The consultative forum sought to establish a shared understanding of the national case for comprehensive cancer education, assess existing institutional provisions, identify essential graduate competencies and explore practical opportunities for integrating cancer education into existing training curricula.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Discussions on the first day focused on Kenya’s cancer control priorities, the National Cancer Control Strategy, cancer data and surveillance, research, and the role of the health workforce in addressing cancer. Participants also examined the proposed institutional self-assessment tool, which will help establish the current status of cancer education, identify gaps, and highlight opportunities for improvement within training institutions.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A key component of the discussions was identifying what every graduating health professional should understand about cancer, regardless of their area of specialization. This included the importance of cancer prevention, risk reduction, early detection, timely referral, patient management and evidence-based practice.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The second day focused on reviewing institutional findings, validating the proposed cancer education framework and identifying practical approaches to curriculum integration. Stakeholders also examined eight proposed cancer education modules, minimum common competencies and a proposed Core\u002FBasic curriculum matrix.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The workshop further explored the Institute’s mandate in setting standards, strengthening quality assurance, supporting cancer research and data systems, and advancing national cancer prevention and control efforts.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Speaking during the engagement, NCI-K Chief Executive Officer, Dr. Elias Melly, provided leadership in framing the workshop’s objectives and guiding discussions on the national priorities for strengthening cancer education.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The consultations also provided an opportunity for training institutions to identify implementation challenges, including curriculum ownership, faculty capacity, clinical exposure, availability of learning resources, and assessment approaches.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The expected outcomes include stakeholder-informed recommendations on the proposed cancer education framework, institution-specific proposals for curriculum integration and a consolidated action plan outlining priority interventions, responsible parties, supporting partners and indicative implementation timelines.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through this initiative, NCI-K seeks to promote a more coordinated and comprehensive approach to cancer education, ensuring that health professionals entering the workforce are better prepared to contribute to cancer prevention, early diagnosis, quality care, and improved patient outcomes.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Towards a Cancer-Free Nation.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C\u002Fp>\n",false,{"rendered":19,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) has convened a two-day National Consultative Workshop aimed at strengthening cancer education in pre-service health professional training programmes across the country. Held from 10–11 November 2026, the workshop brought together stakeholders to deliberate on ways of integrating comprehensive cancer education into the curricula of health professional training institutions, […]\u003C\u002Fp>\n",1,779,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[28],4,[],[31,11,32,33,34,35,36,37],"post-778","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002F1-ps-1024x565.jpg",{"self":40,"collection":46,"about":49,"author":52,"replies":56,"version-history":59,"predecessor-version":62,"wp:featuredmedia":66,"wp:attachment":69,"wp:term":72,"curies":79},[41],{"href":42,"targetHints":43},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F778",{"allow":44},[45],"GET",[47],{"href":48},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[50],{"href":51},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[53],{"embeddable":54,"href":55},true,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F1",[57],{"embeddable":54,"href":58},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=778",[60],{"count":20,"href":61},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F778\u002Frevisions",[63],{"id":64,"href":65},781,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F778\u002Frevisions\u002F781",[67],{"embeddable":54,"href":68},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F779",[70],{"href":71},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=778",[73,76],{"taxonomy":74,"embeddable":54,"href":75},"category","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=778",{"taxonomy":77,"embeddable":54,"href":78},"post_tag","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=778",[80],{"name":81,"href":82,"templated":54},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[84,144,200],{"id":85,"date":86,"date_gmt":86,"guid":87,"modified":89,"modified_gmt":89,"slug":90,"status":10,"type":11,"link":91,"title":92,"content":94,"excerpt":96,"author":20,"featured_media":98,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":99,"categories":101,"tags":103,"class_list":104,"featured_media_src_url":107,"_links":108},707,"2026-09-03T04:12:11",{"rendered":88},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=707","2026-09-03T06:18:42","university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F09\u002F03\u002Funiversity-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration\u002F",{"rendered":93},"University of Manchester Team Visits NCI-K to Explore Opportunities for Cancer Research, Training and Capacity-Building Collaboration",{"rendered":95,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visiting team was received by the \u003Cstrong>NCI-K Chief Executive Officer\u003C\u002Fstrong>, Dr. Elias Melly, who highlighted the Institute’s mandate and its ongoing efforts to strengthen cancer control through research, evidence generation, innovation and strategic partnerships.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large is-resized\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"759\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-1024x759.jpg\" alt=\"\" class=\"wp-image-712\" style=\"aspect-ratio:1.349195973329847;width:563px;height:auto\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-1024x759.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-300x222.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-767x568.jpg 767w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-1536x1138.jpg 1536w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5159-2048x1517.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>From left,\u003C\u002Fstrong> \u003Cstrong>Professor Sacha Howell – Division of Cancer Sciences; Professor Robert Bristow\u003C\u002Fstrong> – \u003Cstrong>Director, Manchester Cancer Research Centre; Dr. Elias Melly, CEO, NCI-k\u003C\u002Fstrong> and \u003Cstrong>Rachel Chown\u003C\u002Fstrong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the visit, the delegation was briefed on the \u003Cstrong>National Cancer Registry\u003C\u002Fstrong>, including cancer data collection, analysis and reporting in Kenya. The team also received a presentation on the \u003Cstrong>NCI-K Cancer Data Dashboard\u003C\u002Fstrong>, showcasing the latest available \u003Cstrong>2024 cancer data\u003C\u002Fstrong> and its role in informing cancer planning, policy, research and service delivery.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation was further taken through \u003Cstrong>research projects supported by NCI-K through its Seed Grant Programme\u003C\u002Fstrong>, highlighting the Institute’s commitment to promoting locally relevant research and building Kenya’s cancer research capacity.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Exploring Areas of Strategic Collaboration\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Discussions focused on areas where the complementary strengths of NCI-K and the Manchester cancer research ecosystem could support advances across the cancer care and research continuum.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A key area was \u003Cstrong>breast cancer screening and imaging\u003C\u002Fstrong>, including strengthening national mammography services, improving screening uptake in rural and urban settings, and exploring the application of \u003Cstrong>artificial intelligence and machine learning in mammographic image interpretation and cancer detection\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also explored opportunities for collaboration in \u003Cstrong>lung cancer screening\u003C\u002Fstrong>, with a focus on generating evidence to inform appropriate screening approaches and strengthening early detection.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Other areas identified included \u003Cstrong>histopathology and diagnostic capacity\u003C\u002Fstrong>, particularly through assessing skills gaps and developing targeted approaches to strengthen specialist expertise, laboratory capacity and cancer diagnostics.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Training, Fellowships and Mentorship\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement also explored opportunities for \u003Cstrong>fellowships, mentorship and structured training programmes\u003C\u002Fstrong> for Kenyan researchers and healthcare professionals. Discussions included the development of \u003Cstrong>online learning modules, short-term training programmes and other flexible professional development opportunities\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These areas align with Manchester’s established strength in cancer education, clinical research and workforce development. The Manchester Cancer Research Centre brings together \u003Cstrong>The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK\u003C\u002Fstrong>, creating an integrated environment in which basic science, translational research and clinical practice are closely connected. The Centre’s research strategy spans multiple cancer types and links basic, translational and clinical research through a wider network of externally funded institutes, centres and research programmes.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Genomics, AI and Precision Cancer Research\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions further identified opportunities for joint research in \u003Cstrong>genomics, artificial intelligence and machine learning\u003C\u002Fstrong>, including the use of advanced technologies to improve cancer diagnosis, understand disease biology and support data-driven cancer research.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Manchester has significant expertise in \u003Cstrong>cancer genomics and data science\u003C\u002Fstrong>, with ongoing international research programmes examining the genetic basis of cancer and opportunities to improve early detection and treatment. Importantly, Manchester already has an active research collaboration in \u003Cstrong>Kenya on oesophageal cancer\u003C\u002Fstrong>, led by Professor Rob Bristow in partnership with Kenyan researchers, focusing on early detection and the genetic changes associated with oesophageal squamous cell cancer.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also discussed opportunities to explore the application of \u003Cstrong>AI in research methodologies\u003C\u002Fstrong>, including innovative approaches to study design and participant randomisation.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement highlighted the potential for NCI-K and Manchester to build on complementary strengths: \u003Cstrong>NCI-K’s national cancer data, research mandate and understanding of Kenya’s cancer landscape\u003C\u002Fstrong>, alongside Manchester’s expertise in \u003Cstrong>cancer genomics, precision oncology, imaging, artificial intelligence, clinical research, translational science, education and multidisciplinary cancer care\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Manchester Cancer Research Centre is a world-leading comprehensive cancer research partnership, bringing together scientists, clinicians and research institutions to accelerate the translation of discoveries into improved cancer prevention, diagnosis and treatment. Its strong international outlook and existing collaborations in Kenya provide a valuable foundation for expanding research and capacity-building partnerships.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K and the University of Manchester will continue discussions to translate the areas identified into practical programmes that can contribute to \u003Cstrong>strengthening cancer research, innovation, early detection, diagnostics, workforce development and cancer control in Kenya\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>University of Manchester Delegation\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation included:\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Rachel Chown\u003C\u002Fstrong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C\u002Fstrong> Rachel previously served at the Manchester Cancer Research Centre, where she led training and education and supported international links, academic collaborations, and research-related education programmes.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Robert Bristow\u003C\u002Fstrong> — \u003Cstrong>Director, Manchester Cancer Research Centre (MCRC); Director, Cancer Research UK Manchester Centre; University Professor of Cancer Studies, University of Manchester; and Senior Group Leader in Translational Oncogenomics at the Cancer Research UK Manchester Institute.\u003C\u002Fstrong> Professor Bristow’s research includes cancer genomics, tumour biology, DNA damage and repair, and treatment response.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Sacha Howell\u003C\u002Fstrong> is a professor in the Division of Cancer Sciences at the University of Manchester and a leading breast cancer clinician-researcher. His research focuses on breast cancer treatment and prevention, breast cancer risk prediction, imaging and mammographic density, with links to research in artificial intelligence and mammographic imaging.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C\u002Fp>\n",{"rendered":97,"protected":17},"\u003Cp>The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building. The visiting team was received by the NCI-K Chief Executive Officer, Dr. Elias Melly, who highlighted the Institute’s […]\u003C\u002Fp>\n",708,{"pagelayer_contact_templates":100,"_pagelayer_content":23,"footnotes":23},[],[28,102],43,[],[105,11,32,33,34,35,36,37,106],"post-707","category-partnerships","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002FDSC_5237-1024x683.jpg",{"self":109,"collection":114,"about":116,"author":118,"replies":120,"version-history":123,"predecessor-version":127,"wp:featuredmedia":131,"wp:attachment":134,"wp:term":137,"curies":142},[110],{"href":111,"targetHints":112},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F707",{"allow":113},[45],[115],{"href":48},[117],{"href":51},[119],{"embeddable":54,"href":55},[121],{"embeddable":54,"href":122},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=707",[124],{"count":125,"href":126},7,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F707\u002Frevisions",[128],{"id":129,"href":130},720,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F707\u002Frevisions\u002F720",[132],{"embeddable":54,"href":133},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F708",[135],{"href":136},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=707",[138,140],{"taxonomy":74,"embeddable":54,"href":139},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=707",{"taxonomy":77,"embeddable":54,"href":141},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=707",[143],{"name":81,"href":82,"templated":54},{"id":145,"date":146,"date_gmt":146,"guid":147,"modified":149,"modified_gmt":149,"slug":150,"status":10,"type":11,"link":151,"title":152,"content":154,"excerpt":156,"author":20,"featured_media":157,"comment_status":158,"ping_status":158,"sticky":17,"template":23,"format":24,"meta":159,"categories":161,"tags":162,"class_list":163,"featured_media_src_url":166,"_links":167},739,"2026-10-16T05:02:06",{"rendered":148},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=739","2026-10-17T07:02:56","nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F10\u002F16\u002Fnci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania\u002F",{"rendered":153},"NCI-K CEO Dr. Elias Melly Delivers Keynote Address at International Cancer Registries Conference in Tanzania",{"rendered":155,"protected":17},"\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Arusha, Tanzania | 14–16 October 2026\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, delivered a keynote address at the IACR–AFCRN–NORA Scientific Conference held at Mount Meru Hotel in Arusha, Tanzania, from 14 to 16 October 2026.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761-1024x768.jpg\" alt=\"\" class=\"wp-image-740\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761-1024x768.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761-300x225.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761-768x576.jpg 768w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761-1536x1152.jpg 1536w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818761.jpg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>NCI-K CEO, Dr. Elias Melly Delivery his Keynote Address at the IACR, Tanzania.\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Melly was featured as the keynote speaker on the opening day of the conference, on 14 October 2026, underscoring Kenya’s participation in regional and international efforts to strengthen cancer prevention and control through research, reliable cancer data and effective surveillance systems.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The scientific conference brought together cancer registry professionals, researchers and public health experts to share scientific evidence, exchange knowledge and discuss approaches to improving cancer registration, surveillance, research and the use of cancer data to inform policy and public health interventions.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Regional and International Partnerships in Cancer Control\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference provided a platform for collaboration among the International Association of Cancer Registries (IACR), the African Cancer Registry Network (AFCRN) and NORA, alongside scientific sessions involving NORA–REACCT–CAN. These collaborative platforms brought together expertise and research from across Africa and other regions to address shared challenges in cancer registration and control.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818758-768x1024-1.jpg\" alt=\"\" class=\"wp-image-741\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818758-768x1024-1.jpg 768w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818758-1152x1536.jpg 1152w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818758.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Dr. Melly (centre)with outgoing IACR President, Dr. Charles Wiggins (right), and the incoming president, Dr. Dabber Wanna (left)\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">For NCI-K, participation in such regional and international scientific engagements reinforces the importance of partnerships in strengthening cancer surveillance, building institutional capacity and generating evidence to guide national cancer control priorities.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Effective cancer control depends on access to quality, timely and reliable data on cancer incidence, mortality, survival and patterns of diagnosis. Strong cancer registration systems help governments and health institutions understand the burden of cancer, identify gaps in services, plan interventions and assess progress in prevention, early detection, treatment and care.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference programme featured discussions on population-based cancer registration, cancer registry governance and standards, data quality and accessibility, cervical cancer screening, cancer survival, and translating registry data into policy and public health action.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya Advances National Childhood Cancer Registry Development\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s contribution to the scientific programme also featured work towards strengthening childhood cancer surveillance. On 15 October 2026, Gladys Chesumbai, Head of the National Cancer Registry at the National Cancer Institute of Kenya presented on “Delphi Consensus for a Standardized National Childhood Cancer Registry Minimum Dataset in Kenya.”\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818752-768x1024-1.jpg\" alt=\"\" class=\"wp-image-742\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818752-768x1024-1.jpg 768w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818752-225x300.jpg 225w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818752-1152x1536.jpg 1152w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818752.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Gladys Chesumbai, Head of Cancer Registry at NCI-K\u003C\u002Fem>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation formed part of a plenary session examining the burden of childhood, adolescent and early-onset cancers. Standardising the minimum dataset for a national childhood cancer registry is an important area of work in strengthening the consistency and quality of information collected on childhood cancers.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable childhood cancer data can support a better understanding of the disease burden, inform research and planning, and provide an evidence base for decisions aimed at improving services for children affected by cancer.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s participation in this scientific exchange highlights the value of sharing national experiences and learning from international expertise as the country advances its cancer surveillance and registry development agenda.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Advancing the National Cancer Control Agenda Through Collaboration\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference’s focus on cancer registration, research, data standards and evidence-informed decision-making aligns with the broader need for coordinated approaches to cancer prevention and control across the region.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As a statutory body established under the Cancer Prevention and Control Act, No. 15 of 2012, NCI-K is mandated to spearhead and coordinate cancer prevention and control in Kenya through the implementation of the National Cancer Control Strategy.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Engagement in regional and international platforms enables the Institute to participate in scientific discussions, strengthen professional networks and contribute to collective efforts to improve cancer information systems and public health responses.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818757-1024x683.jpg\" alt=\"\" class=\"wp-image-743\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818757-1024x683.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818757-300x200.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818757-767x512.jpg 767w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002F818757.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through continued collaboration with national, regional and international stakeholders, NCI-K remains committed to advancing evidence-informed cancer control and supporting efforts towards a cancer-free nation.\u003C\u002Fp>\n\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C\u002Fp>\n",{"rendered":23,"protected":17},0,"closed",{"pagelayer_contact_templates":160,"_pagelayer_content":23,"footnotes":23},[],[20],[],[164,11,32,33,34,36,165],"post-739","category-uncategorized",null,{"self":168,"collection":173,"about":175,"author":177,"replies":179,"version-history":182,"predecessor-version":186,"wp:attachment":190,"wp:term":193,"curies":198},[169],{"href":170,"targetHints":171},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F739",{"allow":172},[45],[174],{"href":48},[176],{"href":51},[178],{"embeddable":54,"href":55},[180],{"embeddable":54,"href":181},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=739",[183],{"count":184,"href":185},3,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F739\u002Frevisions",[187],{"id":188,"href":189},748,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F739\u002Frevisions\u002F748",[191],{"href":192},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=739",[194,196],{"taxonomy":74,"embeddable":54,"href":195},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=739",{"taxonomy":77,"embeddable":54,"href":197},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=739",[199],{"name":81,"href":82,"templated":54},{"id":201,"date":202,"date_gmt":202,"guid":203,"modified":202,"modified_gmt":202,"slug":205,"status":10,"type":11,"link":206,"title":207,"content":209,"excerpt":211,"author":20,"featured_media":213,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":214,"categories":216,"tags":217,"class_list":218,"featured_media_src_url":220,"_links":221},704,"2026-09-01T09:58:04",{"rendered":204},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=704","kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F09\u002F01\u002Fkenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership\u002F",{"rendered":208},"Kenya Announces Major Reduction in Cancer Treatment Costs Through Pfizer Partnership",{"rendered":210,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating several cancers by more than seven times, with the cost of some medicines expected to fall from as much as KSh. 1 million to below KSh. 50,000 per treatment cycle.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The development follows discussions between President William Ruto and Pfizer Chairman and Chief Executive Officer Albert Bourla during their meeting at State House, Nairobi.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement covers medicines used in the treatment of breast, stomach, colorectal, lung, prostate and oesophageal cancers, as well as leukaemia, lymphoma and multiple myeloma.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>“Today, Kenya has made a breakthrough in the treatment of several cancers,” President Ruto said.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The arrangement brings together Pfizer and the Kenya Medical Supplies Authority (KEMSA) under Pfizer’s \u003Cem>Accord for a Healthier World\u003C\u002Fem>, a global initiative through which the company provides medicines to lower-income countries on a not-for-profit basis. Kenya joined the Accord in June 2025.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The significant reduction in medicine costs is expected to improve access to cancer treatment and ease the financial burden faced by patients and their families. According to the President, the lower prices will enable the Social Health Authority (SHA) KSh. 800,000 cancer package to fully cover treatment, substantially reducing the need for additional out-of-pocket payments.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement will also provide Kenya with access to newer cancer therapies, helping address delays that patients have historically experienced in accessing innovative and potentially life-saving treatments.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>In addition, Pfizer is expected to make relevant technologies and newer medicines available to support local pharmaceutical manufacturing in Africa, contributing to efforts to strengthen the continent’s capacity to produce essential medical commodities.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>This development comes at a critical time as cancer continues to pose a major public health challenge in Kenya. The high cost of diagnosis and treatment has for years placed a significant financial burden on patients and families, with some patients unable to complete their prescribed treatment.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) welcomes this landmark development as an important step towards advancing equitable access to quality, affordable and timely cancer care. The partnership reinforces Kenya’s commitment to reducing the financial barriers to cancer treatment and strengthening the country’s broader cancer control efforts.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Towards a Cancer-Free Nation.\u003C\u002Fstrong>\u003C\u002Fp>\n",{"rendered":212,"protected":17},"\u003Cp>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines. The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating […]\u003C\u002Fp>\n",705,{"pagelayer_contact_templates":215,"_pagelayer_content":23,"footnotes":23},[],[20],[],[219,11,32,33,34,35,36,165],"post-704","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F09\u002F5807a4d5-f491-4f23-9e6d-150ccd688d09_HREKm0GXkAElEp1-og_image.webp",{"self":222,"collection":227,"about":229,"author":231,"replies":233,"version-history":236,"predecessor-version":239,"wp:featuredmedia":243,"wp:attachment":246,"wp:term":249,"curies":254},[223],{"href":224,"targetHints":225},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F704",{"allow":226},[45],[228],{"href":48},[230],{"href":51},[232],{"embeddable":54,"href":55},[234],{"embeddable":54,"href":235},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=704",[237],{"count":20,"href":238},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F704\u002Frevisions",[240],{"id":241,"href":242},706,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F704\u002Frevisions\u002F706",[244],{"embeddable":54,"href":245},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F705",[247],{"href":248},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=704",[250,252],{"taxonomy":74,"embeddable":54,"href":251},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=704",{"taxonomy":77,"embeddable":54,"href":253},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=704",[255],{"name":81,"href":82,"templated":54}]